- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01312090
Chronic Intermittent Cold Exposure on Weight Loss (CICE)
September 5, 2012 updated by: Sanna Kaye, Helsinki University Central Hospital
- To test whether chronic intermittent cold exposure is more effective in programmed body weight loss when compared to conventional programmed weight loss.
- To measure the metabolic responses (e.g. in the white and brown adipose tissue, muscle and circulating markers) of treatment with chronic intermittent cold exposure and conventional treatment
- To measure tissue specific changes of weight loss and the treatment with chronic intermittent cold exposure in glucose uptake rate in adipose organ (white and brown adipose tissue), liver, myocardium, skeletal muscle and brain
- To measure tissue specific biochemical indicators before and after treatment with chronic intermittent cold exposure from white adipose tissue and skeletal muscle.
- To compare changes in body composition and fat distribution after weight loss using chronic cold exposure or using conventional method
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI > 30 (inclusive)
- Body weight less than 120 kg
- Weight stability for 3 months
- Plasma triglyceride concentration less than 3.0 mmol/l
- Plasma HDL-cholesterol more than 0.9 mmol/l in males and more than 1.0 mmol/l in females
- Blood pressure less than 140/90 mmHg (inclusive)
- Normal glucose tolerance or impaired glucose tolerance but not diabetes (fasting glucose < 7.0 mmol/l or 2 h glucose in the oral glucose tolerance test < 11.1 mmol/l)
Exclusion Criteria:
- Smoking
- Frequent weight loss attempts
- Pregnancy or lactation
- Diabetes mellitus
- Hypo/hyperthyreosis
- Cardiovascular disease, stroke or neurological disorder
- Medication (antihypertensive and antidiabetic drugs, lipid lowering drugs, antidepressants, corticosteroids)
- Claustrophobia
- Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results.
- Presence of any ferromagnetic objects that would make MRI imaging contraindicated
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Conventional weight loss treatment group
Eating and physical activity counseling and behavioral therapy for weight loss.
|
Weight loss intervention with Very Low Calory Diet (VLCD, 500-1000 kcal / d + dietary supplements) and group and individual treatment (eating, physical activity counseling and behavioural therapy).
|
|
Experimental: Cryo group
Eating and physical activity counseling and behavioral therapy for weight loss will be provided to all subjects. The subjects in the cryo group will be given whole-body cryotherapy 1-3 times a week for the 4-month-treatment period |
Cryotherapy: The whole-cody cryotherapy device (Univers Cryo-Combi;Oy MJG Univers Ab, Helsinki, Finland) consists of 3 chambers set at different temperatures.
The first 2 chambers are meant for precooling (-30°Cand-60°C), and the patient remains in these for a very short time.
The third chamber temperature reaches -110°C, and the patient remains inside for 3-4 minutes wearing a bathing suit or trunks, acral parts covered.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
weight loss
Time Frame: looking forward using periodic observations collected predominantly during 12 months following subject enrollment
|
Effect of chronic intermittent cold exposure and conventional treatment on weight loss
|
looking forward using periodic observations collected predominantly during 12 months following subject enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glucose uptake
Time Frame: 4 months from admission
|
Effect of chronic intermittent cold exposure and conventional treatment on glucose uptake of brown and white adipose tissue, liver, myocardium, skeletal muscle and brain (PET-scan).
|
4 months from admission
|
|
energy metabolism
Time Frame: 12 months from admission
|
Effect of chronic intermittent cold exposure and conventional treatment on energy metabolism
|
12 months from admission
|
|
behavioural patterns
Time Frame: 12 months from admission
|
Effect of chronic intermittent cold exposure and conventional treatment on behavioural patterns
|
12 months from admission
|
|
muscle metabolism
Time Frame: 12 months from admission
|
Effect of chronic intermittent cold exposure and conventional treatment on muscle metabolism
|
12 months from admission
|
|
white adipose tissue metabolism
Time Frame: 12 months from admission
|
Effect of chronic intermittent cold exposure and conventional treatment on white adipose tissue metabolism
|
12 months from admission
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Kirsi H Pietilainen, MD, PhD, Obesity research Unit, Department of Medicine, Helsinki University Central Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Actual)
June 1, 2011
Study Completion (Actual)
June 1, 2011
Study Registration Dates
First Submitted
March 7, 2011
First Submitted That Met QC Criteria
March 9, 2011
First Posted (Estimate)
March 10, 2011
Study Record Updates
Last Update Posted (Estimate)
September 6, 2012
Last Update Submitted That Met QC Criteria
September 5, 2012
Last Verified
September 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PS09RUSRAS
- T1070RUSRA (Other Identifier: Helsinki University Central Hospital registry)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on counseling and behavioral therapy for weight loss
-
Yale UniversityCompletedWeight Loss | Overweight and Obesity | Food AddictionUnited States
-
University of California, San DiegoSan Diego State University; American Cancer Society, Inc.Completed
-
The Miriam HospitalCompleted
-
University of Massachusetts, WorcesterNational Institute of Mental Health (NIMH)CompletedDepression | ObesityUnited States
-
The University of Texas Health Science Center,...Not yet recruiting
-
Drexel UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Yale...CompletedBinge-Eating Disorder | Weight Loss | Binge Eating | Eating DisorderUnited States
-
Oregon Health and Science UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedMetabolic Diseases | Obesity | Insulin Resistance | Prediabetic State | Metabolic Syndrome XUnited States
-
Drexel UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Office...CompletedObesity | Overweight | Weight Loss | Overweight and ObesityUnited States
-
University of PennsylvaniaNational Institute of Nursing Research (NINR)Completed
-
Lora BurkeNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed